| Name | Title | Contact Details |
|---|---|---|
Peter Vladimirov |
Chief Technology Officer | Profile |
Glacier County EMS is a Cut Bank, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hospice by the Sea is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Medical Solutions, we connect care for our clients, traveling nurses and clinicians, and our internal employees. We help our clients find the perfect clinical, community and cultural fit with their traveling nurses and staff. Our travelers receive the best service in the industry from recruiters invested in their professional and personal success. Our employees work for a mission they believe in, with pride of representing one of the most respected brands in the healthcare staffing industry. We serve acute-care hospitals, post-acute care facilities, community health centers and other healthcare settings nationwide. We offer travel staffing as well as a managed service provider (MSP) program, strike solutions for hospitals, and a rapid response program for hospitals with urgent, flexible staffing needs. Our dedicated Client Managers ensure your facility`s unique needs, challenges and goals are met in a cost-effective manner.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Jackson Health System is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Miami, FL. To find more information about Jackson Health System, please visit www.jhsmiami.org